Quality Inspector II 3rd Shift jobs in United States
cer-icon
Apply on Employer Site
company-logo

Bausch + Lomb · 11 hours ago

Quality Inspector II 3rd Shift

Bausch + Lomb is a leading global eye health company dedicated to enhancing sight for millions. The MQA Line Inspector is responsible for performing quality inspections on finished and contract goods, ensuring compliance with regulations and assisting in quality decision-making.

Health CareHealth DiagnosticsMedical
badNo H1Bnote

Responsibilities

Utilizes statistical sampling plans to perform visual and functional inspections of contract and Greenville finished product
Documents all results in the QA batch record or on the Receiving Inspection Report
Assists in quality decisions for nonconforming product and provides QA inspection support to the Manufacturing operation
Assists in the Investigation and documentation of process issues that occur during the production operation including input to in-process product quality decisions
Maintains retain sample inventory for all finished product

Qualification

Quality inspectionStatistical samplingDimensional inspectionComputer skillsPeople skillsCommunication skillsDecision-making

Required

High School Diploma required
2-3 years prior manufacturing or inspection experience required
Prior exposure to visual and dimensional inspection required
Pallet Jack and Fork lift training required
Excellent written and verbal communication skills demonstrated
Good people skills
Must be able to communicate with a cross functional team and management concerning quality issues
Decision-making ability and ability to work unsupervised expected

Preferred

Previous inspection experience using balances and dimensional tools preferred
Computer skills using MS Excel, MS Word, MS Outlook, MS Access, Warehouse Management System (ERPLX) and Document Management System (Documentum)

Benefits

Employee Benefits: Bausch + Lomb

Company

Bausch + Lomb

company-logo
We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life.

Funding

Current Stage
Public Company
Total Funding
$4.98B
Key Investors
JP Morgan
2025-12-12Post Ipo Debt· $2.8B
2025-06-18Post Ipo Debt· $776.8M
2023-09-11Post Ipo Debt· $1.4B

Leadership Team

leader-logo
Brent Saunders
Chairman and CEO
linkedin
leader-logo
Robert Bertolini
President & CFO
Company data provided by crunchbase